𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer

✍ Scribed by Alain Lortholary; Anne-Claire Hardy-Bessard; Thomas Bachelot; Gaëtan de Rauglaudre; Jérôme Alexandre; Hugues Bourgeois; Dominique Jaubert; Désiré Paraiso; Rémy Largillier

Book ID
106379453
Publisher
Springer US
Year
2011
Tongue
English
Weight
260 KB
Volume
131
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized phase 2 trial comparing 3-h
A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer
✍ Stacy L. Moulder; Frankie A. Holmes; Anthony W. Tolcher; Peter Thall; Kristine B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

## Abstract ## BACKGROUND: This study was performed to compare efficacy and toxicity profiles of paclitaxel using 3‐hour versus 96‐hour infusion schedules. ## METHODS: Patients with metastatic breast cancer (MBC) were randomly assigned to receive paclitaxel starting at a dose of 250 mg/m^2^ intr

Randomized multicenter Phase II trial of
Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma
✍ Emilio Bajetta; Maria Di Bartolomeo; Luigi Mariani; Antonio Cassata; Salvatore A 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

## Abstract ## BACKGROUND The aim of the current randomized Phase II study was to investigate the efficacy and safety of capecitabine combined with irinotecan as first‐line treatment in metastatic colorectal carcinoma (CRC). ## METHODS A total of 140 patients received capecitabine at a dose of 1